News
IVVD
0.6114
+0.36%
0.0022
Weekly Report: what happened at IVVD last week (0720-0724)?
Weekly Report · 4h ago
Invivyd Receives Nasdaq Notice for Bid Price Deficiency
TipRanks · 2d ago
Invivyd gets Nasdaq notice after shares trade below $1 minimum bid price
PUBT · 2d ago
Weekly Report: what happened at IVVD last week (0713-0717)?
Weekly Report · 07/20 09:38
Weekly Report: what happened at IVVD last week (0706-0710)?
Weekly Report · 07/13 09:39
Analysts Conflicted on These Healthcare Names: Cipher Pharmaceuticals (OtherCPHRF), Invivyd (IVVD) and Merck & Company (MRK)
TipRanks · 07/09 12:40
Invivyd: Buy Rating Reiterated as PEMGARDA EUA Transition Seen as Administrative; $10 Price Target Unchanged
TipRanks · 07/08 10:15
Invivyd Price Target Maintained With a $10.00/Share by BTIG
Dow Jones · 07/07 09:48
BTIG Reiterates Buy on Invivyd, Maintains $10 Price Target
Benzinga · 07/07 09:37
FDA to End Emergency Use Authorization For Invivyd's Covid-19 Prevention Shot
Dow Jones · 07/06 15:58
Invivyd gets notice of Pemgarda EUA termination
Seeking Alpha · 07/06 11:36
Invivyd Plans Post-EUA Pathway for PEMGARDA Antibody
TipRanks · 07/06 11:28
Invivyd announces notice of termination for Pemgarda Emergency Use Authorization
TipRanks · 07/06 11:20
Invivyd says FDA sets June 29, 2027 termination date for Pemgarda EUA
PUBT · 07/06 11:13
The FDA Sent Invivyd An Advance Termination Notice For Pemgarda (Pemivibart) Emergency Use Authorization Following US Department Of Health And Human Services’ Announcement Of Advanced Notice Of Termination Of Covid-19 EUA Declaration On June 30, With Effective Date Of June 29, 2027
Benzinga · 07/06 11:11
INVIVYD - IN DIALOGUE WITH FDA ON NEXT STEPS FOR PEMGARDA
Reuters · 07/06 11:01
INVIVYD ANNOUNCES RECEIPT OF TWELVE MONTHS’ ADVANCED NOTICE OF EMERGENCY USE AUTHORIZATION (EUA) TERMINATION FOR PEMGARDA® AND PROVIDES AN UPDATE ON NEXT STEPS WITH THE U.S. FDA
Reuters · 07/06 11:01
Weekly Report: what happened at IVVD last week (0629-0703)?
Weekly Report · 07/06 09:41
Invivyd grants 493,000 stock options to 14 new hires at $0.85 per share
PUBT · 07/02 11:01
NOVABRIDGE BIOSCIENCES APPOINTS DR. SRISHTI GUPTA AS CHIEF EXECUTIVE OFFICER
Reuters · 06/29 11:00
More
Webull provides a variety of real-time IVVD stock news. You can receive the latest news about Invivyd through multiple platforms. This information may help you make smarter investment decisions.
About IVVD
Invivyd, Inc. is a biopharmaceutical company. The Company’s proprietary INVYMAB platform approach combines state-of-the-art viral surveillance and predictive modeling with advanced antibody engineering. INVYMAB is designed to facilitate the rapid, serial generation of new monoclonal antibodies (mAbs) to keep pace with evolving viral threats. The Company delivers antibody-based therapies that protect vulnerable people from the devastating consequences of circulating viral threats, such as SARS-CoV-2. Its PEMGARDA (pemivibart) is the Company's first mAb to receive regulatory authorization and is designed to keep pace with SARS-CoV-2 viral evolution. PEMGARDA is used for the pre-exposure prophylaxis (prevention) of COVID-19 in adults and adolescents. Its VYD2311 is optimized for neutralization potency against SARS-CoV-2 lineages such as BA.2.86 and JN.1. The Company also has additional anti-SARS-CoV-2 mAb candidates in discovery and pre-clinical characterization.